Atlas Trials

Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya Patients

Clinical trial NCT03882060 · UNKNOWN

Trial details

NCT number
NCT03882060
Sponsor
Seoul National University Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Moyamoya DiseasePediatricsCerebrovascular Disorders
Start date
2019-04-08
Primary completion
2023-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.